© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Khiron Life Sciences Corp. (KHRNF) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 11K |
| Aug 04, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 4K |
| Aug 03, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 2.5K |
| Jul 10, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 3.18K |
| Jul 09, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1K |
| Jul 07, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1K |
| Jul 06, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 9.77K |
| Jun 22, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 14.3K |
| May 18, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 6.14K |
| May 13, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 500 |
| May 04, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 250 |
| Apr 21, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 5.1K |
| Apr 13, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 10K |
| Mar 27, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 570 |
| Mar 25, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1.2K |
| Dec 22, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 3.9K |
| Dec 19, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1.81K |
| Sep 30, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 100 |
| Sep 29, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 2.5K |
| Sep 26, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1K |
Khiron Life Sciences Corp. operates as a comprehensive medical and cannabis enterprise, extending its operations across Latin America and Europe. The company's business is structured into three primary segments: Health Services, Medical Cannabis Products, and Wellbeing Products. A core focus for Khiron involves the end-to-end process of medical cannabis, encompassing the cultivation, manufacturing, distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) varieties. Additionally, the company manages a network of health centers and satellite clinics, notably under the ILANS and Zerenia brands. It also develops CBD-based cosmeceutical items, specifically marketed under its Kuida brand. Its healthcare footprint includes running Zerenia clinics in key locations such as Medellin and Peru. Khiron Life Sciences Corp. was founded in 2012 and maintains its corporate headquarters in Vancouver, Canada.
| Employees | 310 |
| Beta | 5.43 |
| Sales or Revenue | $12.80M |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |